Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Bile Duct Neoplasms × Melphalan × Clear all

Sponsor

Conditions

Multiple Myeloma 107 Lymphoma 48 Lymphoma, Non-Hodgkin 44 Hodgkin Disease 44 Leukemia, Myeloid, Acute 41 Myelodysplastic Syndromes 40 Leukemia 34 Precursor Cell Lymphoblastic Leukemia-Lymphoma 33 Leukemia, Lymphocytic, Chronic, B-Cell 28 Lymphoma, Mantle-Cell 26 Neoplasms, Plasma Cell 25 Lymphoma, Large B-Cell, Diffuse 24 Lymphoma, Follicular 24 Lymphoma, B-Cell, Marginal Zone 18 Burkitt Lymphoma 18 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 17 Myeloproliferative Disorders 16 Recurrence 14 Immunoglobulin Light-chain Amyloidosis 14 Congenital Abnormalities 13 Primary Myelofibrosis 12 Lymphoma, Large-Cell, Immunoblastic 12 Leukemia, Myeloid, Accelerated Phase 12 Hematologic Neoplasms 12 Waldenstrom Macroglobulinemia 10 Lymphoma, T-Cell, Cutaneous 10 Leukemia, Myelomonocytic, Juvenile 10 Leukemia, Myelomonocytic, Chronic 10 Leukemia, Myeloid, Chronic-Phase 10 Dendritic Cell Sarcoma, Interdigitating 10

Interventions

Gemcitabine 12 Capecitabine 8 Cisplatin 7 pembrolizumab 4 Fluorouracil 4 Sorafenib 3 Oxaliplatin 3 Erlotinib Hydrochloride 3 trametinib 2 regorafenib 2 N-(3-chloro-4-((3-fluorobenzyl)oxy)phenyl-6-(5-((methylsulfonyl)ethyl)aminomethyl)-2-furyl)-4-quinazolinamine 2 Leucovorin 2 Lapatinib 2 trifluridine tipiracil drug combination 1 tremelimumab 1 spartalizumab 1 seribantumab 1 olutasidenib 1 durvalumab 1 devimistat 1 derazantinib 1 dehydroftorafur 1 cediranib 1 cabozantinib 1 Trifluridine 1 Trastuzumab 1 Therapeutics 1 Sutures 1 Surgical Instruments 1 Standard of Care 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡